ConcertAI Database is a clinical research site located in Cambridge, Massachusetts, United States 02138.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
ConcertAI Database has participated in 2 clinical trials.
Therapeutic areas: Advanced/Metastatic NSCLC, Advanced/Metastatic HER2-negative Breast Cancer, Non-small Cell Lung Cancer.
Sponsors: Daiichi Sankyo.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
ConcertAI Database has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
ConcertAI Database has 2 clinical trials on record. Their work covers Advanced/Metastatic NSCLC, Advanced/Metastatic HER2-negative Breast Cancer, Non-small Cell Lung Cancer.
ConcertAI Database has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.